Información del producto
TC-S 7003 is a small-molecule drug that has been orally administered in clinical trials for the treatment of inflammatory diseases. TC-S 7003 has been shown to inhibit the activation of kinase signaling pathways, which are involved in cancer and hematopoietic cell proliferation. TC-S 7003 binds to collagen and inhibits the degradation of collagen by inhibiting matrix metalloproteinases (MMPs), which cause inflammation. TC-S 7003 also prevents the mitochondrial membrane potential from decreasing, as this will lead to an increase in reactive oxygen species (ROS) production and cell death.
Propiedades químicas
Consulta técnica sobre: 3D-XIB95009 TC-S 7003
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
